8-K: Waystar Reports Strong Q2 2026 Results, Raises Guidance

Waystar Holding Corp. announced robust second quarter 2026 financial results, exceeding expectations with an 18% year-over-year revenue increase and raising full-year guidance.

Summary

• Waystar Holding Corp. reported strong financial results for the second quarter ended June 30, 2026.
• Revenue increased by 18% year-over-year to $319.7 million.
• GAAP net income was $40.9 million, or $0.21 per diluted share.
• Non-GAAP net income reached $83.3 million, or $0.43 per diluted share.
• Adjusted EBITDA was $136.7 million, with an adjusted EBITDA margin of 43%.
• The company is raising its full-year 2026 revenue and adjusted EBITDA guidance.
• Key performance metrics show continued growth, with a net revenue retention rate of 108%.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive report due to strong revenue growth, improved profitability metrics, and an upward revision of future guidance, indicating solid operational performance and market position.

Positives

• Revenue growth of 18% year-over-year to $319.7 million.
• Strong net income of $40.9 million (GAAP) and $83.3 million (non-GAAP).
• Healthy adjusted EBITDA of $136.7 million, with a 43% margin.
• Raising full-year 2026 revenue and adjusted EBITDA guidance.
• Net revenue retention rate of 108% indicates strong client loyalty and expansion.
• Subscription revenue increased by 34% year-over-year, highlighting a shift towards recurring revenue streams.
• Provider revenue grew by 23% year-over-year, demonstrating strong adoption within the healthcare provider segment.

Negatives

• While revenue is up, volume-based revenue saw a more modest increase of 3% year-over-year.
• Net income margin, while improved from the prior year, remains at 13%.

Risks

• The company operates in a highly competitive industry.
• Ability to retain existing clients and attract new ones is crucial.
• Risks associated with integrating acquired businesses, such as the Iodine acquisition.
• Dependence on senior management and key employees.
• Potential for cybersecurity breaches and data privacy incidents.
• The complex and evolving healthcare regulatory landscape.
• Substantial debt and restrictive covenants in credit agreements.

Future Outlook

For the full fiscal year 2026, Waystar now expects total revenue to be between $1.276 billion and $1.294 billion, adjusted EBITDA between $535 million and $545 million, and non-GAAP net income between $322 million and $340 million, translating to diluted non-GAAP net income per share between $1.61 and $1.70.

Management Comments

• "Waystar delivered another solid quarter, driven by healthy demand, disciplined execution, and growing provider adoption," said Matt Hawkins, Chief Executive Officer of Waystar.
• "Our unique position connecting providers, payers, and patients combined with the breadth of our platform, the scale of our data, and the accelerating impact of our AltitudeAI capabilities helps clients improve performance and reinforces our confidence in the long-term opportunity ahead."

Industry Context

StockSavvy.ai notes that Waystar's strong performance in Q2 2026, particularly its revenue growth and raised guidance, aligns with a trend of increasing demand for integrated healthcare payment solutions. The company's focus on AI capabilities like AltitudeAI positions it to capitalize on the industry's push for efficiency and data-driven decision-making.

Comparison to Industry Standards

• Waystar's 18% year-over-year revenue growth in Q2 2026 is robust compared to many established players in the broader FinTech sector, which often see single-digit growth.
• The 43% adjusted EBITDA margin is strong for a software-as-a-service (SaaS) company, indicating efficient operations and scalability. This margin is generally considered high within the healthcare IT and revenue cycle management segments.
• A Net Revenue Retention Rate (NRR) of 108% is considered excellent, surpassing the benchmark of 100% often targeted by SaaS companies, signifying effective upselling and cross-selling to existing clients.
• While specific direct competitors' Q2 2026 results are not provided in this filing, Waystar's performance suggests it is outperforming or meeting high expectations within its niche of healthcare payment software.

Legal Proceedings

• The filing references potential legal proceedings and evolving healthcare regulatory frameworks as risks, but does not detail any current specific legal matters.

Related Party Transactions

• Related party interest expense of $1.011 million for the three months ended June 30, 2026, and $1.944 million for the six months ended June 30, 2026.

Stakeholder Impact

• Shareholders: Positive impact expected from strong financial performance and raised guidance, potentially leading to increased stock value.
• Employees: Continued growth and investment in AI may lead to new opportunities and job security.
• Clients (Providers, Payers, Patients): Benefit from improved healthcare payment processes and potentially enhanced financial performance through Waystar's solutions.
• Creditors: Improved financial health and cash flow generation strengthen the company's ability to service debt.

Next Steps

• Continue to monitor client adoption and the impact of AltitudeAI capabilities.
• Focus on integrating acquired businesses effectively.
• Execute on strategies to grow revenue and maintain profitability.
• Prepare for the upcoming conference call to discuss results in detail.

Key Dates

Recommendation

The company delivered better-than-expected results and raised guidance, which is positive. However, the valuation and broader market conditions, along with inherent risks in the healthcare IT sector, suggest a 'hold' rating is prudent for seasoned investors until further sustained performance or clearer market trends emerge.

Keywords

healthcare payment software, revenue growth, adjusted EBITDA, net income, financial results, guidance, net revenue retention, subscription revenue